Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

New Brunswick, NJ (February 9th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8th. Joseph J. Wolk, Executive Vice President and Chief Financial Officer, will represent the Company in a session scheduled at 1:05 p.m. (Eastern Time). This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.A webcast replay will be available approximately 48-hrs after the live webcast.
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Latest News Source Type: news